Selected research
Industry Growth & Trends
Global Artificial Intelligence Medical Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Artificial Intelligence Medical Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Artificial Intelligence Medical Software market include 2bPrecise, CliniSys, Fabric Genomics, Flatiron Health, Foundation Medicine, Gene42, Human Longevity, IBM and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Artificial Intelligence Medical Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Artificial Intelligence Medical Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Intelligence Medical Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Intelligence Medical Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Artificial Intelligence Medical Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Artificial Intelligence Medical Software Market by Company
2bPrecise
CliniSys
Fabric Genomics
Flatiron Health
Foundation Medicine
Gene42
Human Longevity
IBM
Koninklijke Philips
LifeOmic Health
Pierian
SOPHiA GENETICS
Syapse
Tempus
Translational Software
Artificial Intelligence Medical Software Segment by Type
Image Recognition
Natural Language Processing
Others
Artificial Intelligence Medical Software Segment by Application
Drug Discovery
Precision Medicine
Others
Artificial Intelligence Medical Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Medical Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Medical Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Medical Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Artificial Intelligence Medical Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Image Recognition
- Natural Language Processing
- Others
Applications
- Drug Discovery
- Precision Medicine
- Others
Companies covered
- 2bPrecise
- CliniSys
- Fabric Genomics
- Flatiron Health
- Foundation Medicine
- Gene42
- Human Longevity
- IBM
- Koninklijke Philips
- LifeOmic Health
- Pierian
- SOPHiA GENETICS
- Syapse
- Tempus
- Translational Software
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Artificial Intelligence Medical Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Artificial Intelligence Medical Software Market Size by Region (2021-2032)
- 1.4.1 Global Artificial Intelligence Medical Software Market Size by Region (2021-2026)
- 1.4.2 Global Artificial Intelligence Medical Software Market Size by Region (2027-2032)
- 1.5 Key Regions Artificial Intelligence Medical Software Market Size (2021-2032)
- 1.5.1 North America Artificial Intelligence Medical Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Artificial Intelligence Medical Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Artificial Intelligence Medical Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Artificial Intelligence Medical Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Artificial Intelligence Medical Software Market Size Growth Rate (2021-2032)
2 Artificial Intelligence Medical Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Image Recognition
- 2.1.2 Natural Language Processing
- 2.1.3 Others
- 2.2 Global Artificial Intelligence Medical Software Market Size by Type
- 2.2.1 Global Artificial Intelligence Medical Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Artificial Intelligence Medical Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Artificial Intelligence Medical Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Artificial Intelligence Medical Software Market Size by Regions
- 2.3.1 North America Artificial Intelligence Medical Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Artificial Intelligence Medical Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Artificial Intelligence Medical Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Artificial Intelligence Medical Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Artificial Intelligence Medical Software Market Size Breakdown by Type (2021-2026)
3 Artificial Intelligence Medical Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug Discovery
- 3.1.2 Precision Medicine
- 3.1.3 Others
- 3.2 Global Artificial Intelligence Medical Software Market Size by Application
- 3.2.1 Global Artificial Intelligence Medical Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Artificial Intelligence Medical Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Artificial Intelligence Medical Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Artificial Intelligence Medical Software Market Size by Regions
- 3.3.1 North America Artificial Intelligence Medical Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Artificial Intelligence Medical Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Artificial Intelligence Medical Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Artificial Intelligence Medical Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Artificial Intelligence Medical Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Artificial Intelligence Medical Software Industry Trends
- 4.2 Artificial Intelligence Medical Software Industry Drivers
- 4.3 Artificial Intelligence Medical Software Industry Opportunities and Challenges
- 4.4 Artificial Intelligence Medical Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Artificial Intelligence Medical Software Revenue (2021-2026)
- 5.2 Global Artificial Intelligence Medical Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Artificial Intelligence Medical Software Key Company Headquarters & Area Served
- 5.4 Global Artificial Intelligence Medical Software Company, Product Type & Application
- 5.5 Global Artificial Intelligence Medical Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Artificial Intelligence Medical Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Artificial Intelligence Medical Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Artificial Intelligence Medical Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 2bPrecise
- 6.1.1 2bPrecise Company Information
- 6.1.2 2bPrecise Business Overview
- 6.1.3 2bPrecise Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 2bPrecise Artificial Intelligence Medical Software Product Portfolio
- 6.1.5 2bPrecise Recent Developments
- 6.2 CliniSys
- 6.2.1 CliniSys Company Information
- 6.2.2 CliniSys Business Overview
- 6.2.3 CliniSys Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CliniSys Artificial Intelligence Medical Software Product Portfolio
- 6.2.5 CliniSys Recent Developments
- 6.3 Fabric Genomics
- 6.3.1 Fabric Genomics Company Information
- 6.3.2 Fabric Genomics Business Overview
- 6.3.3 Fabric Genomics Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fabric Genomics Artificial Intelligence Medical Software Product Portfolio
- 6.3.5 Fabric Genomics Recent Developments
- 6.4 Flatiron Health
- 6.4.1 Flatiron Health Company Information
- 6.4.2 Flatiron Health Business Overview
- 6.4.3 Flatiron Health Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Flatiron Health Artificial Intelligence Medical Software Product Portfolio
- 6.4.5 Flatiron Health Recent Developments
- 6.5 Foundation Medicine
- 6.5.1 Foundation Medicine Company Information
- 6.5.2 Foundation Medicine Business Overview
- 6.5.3 Foundation Medicine Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Foundation Medicine Artificial Intelligence Medical Software Product Portfolio
- 6.5.5 Foundation Medicine Recent Developments
- 6.6 Gene42
- 6.6.1 Gene42 Company Information
- 6.6.2 Gene42 Business Overview
- 6.6.3 Gene42 Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Gene42 Artificial Intelligence Medical Software Product Portfolio
- 6.6.5 Gene42 Recent Developments
- 6.7 Human Longevity
- 6.7.1 Human Longevity Company Information
- 6.7.2 Human Longevity Business Overview
- 6.7.3 Human Longevity Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Human Longevity Artificial Intelligence Medical Software Product Portfolio
- 6.7.5 Human Longevity Recent Developments
- 6.8 IBM
- 6.8.1 IBM Company Information
- 6.8.2 IBM Business Overview
- 6.8.3 IBM Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 IBM Artificial Intelligence Medical Software Product Portfolio
- 6.8.5 IBM Recent Developments
- 6.9 Koninklijke Philips
- 6.9.1 Koninklijke Philips Company Information
- 6.9.2 Koninklijke Philips Business Overview
- 6.9.3 Koninklijke Philips Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Koninklijke Philips Artificial Intelligence Medical Software Product Portfolio
- 6.9.5 Koninklijke Philips Recent Developments
- 6.10 LifeOmic Health
- 6.10.1 LifeOmic Health Company Information
- 6.10.2 LifeOmic Health Business Overview
- 6.10.3 LifeOmic Health Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 LifeOmic Health Artificial Intelligence Medical Software Product Portfolio
- 6.10.5 LifeOmic Health Recent Developments
- 6.11 Pierian
- 6.11.1 Pierian Company Information
- 6.11.2 Pierian Business Overview
- 6.11.3 Pierian Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Pierian Artificial Intelligence Medical Software Product Portfolio
- 6.11.5 Pierian Recent Developments
- 6.12 SOPHiA GENETICS
- 6.12.1 SOPHiA GENETICS Company Information
- 6.12.2 SOPHiA GENETICS Business Overview
- 6.12.3 SOPHiA GENETICS Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 SOPHiA GENETICS Artificial Intelligence Medical Software Product Portfolio
- 6.12.5 SOPHiA GENETICS Recent Developments
- 6.13 Syapse
- 6.13.1 Syapse Company Information
- 6.13.2 Syapse Business Overview
- 6.13.3 Syapse Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Syapse Artificial Intelligence Medical Software Product Portfolio
- 6.13.5 Syapse Recent Developments
- 6.14 Tempus
- 6.14.1 Tempus Company Information
- 6.14.2 Tempus Business Overview
- 6.14.3 Tempus Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Tempus Artificial Intelligence Medical Software Product Portfolio
- 6.14.5 Tempus Recent Developments
- 6.15 Translational Software
- 6.15.1 Translational Software Company Information
- 6.15.2 Translational Software Business Overview
- 6.15.3 Translational Software Artificial Intelligence Medical Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Translational Software Artificial Intelligence Medical Software Product Portfolio
- 6.15.5 Translational Software Recent Developments
7 North America
- 7.1 North America Artificial Intelligence Medical Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Artificial Intelligence Medical Software Market Size by Country (2021-2026)
- 7.3 North America Artificial Intelligence Medical Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Artificial Intelligence Medical Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Artificial Intelligence Medical Software Market Size by Country (2021-2026)
- 8.3 Europe Artificial Intelligence Medical Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Artificial Intelligence Medical Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Artificial Intelligence Medical Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Artificial Intelligence Medical Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Artificial Intelligence Medical Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Artificial Intelligence Medical Software Market Size by Country (2021-2026)
- 10.3 South America Artificial Intelligence Medical Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Intelligence Medical Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Artificial Intelligence Medical Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Artificial Intelligence Medical Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst